Recent advances in radiotherapy

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Bhide, S A ^a   Nutting, C M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DOSIMETRY; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; IMAGE ANALYSIS; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; FEMALE; HEAD AND NECK TUMOR; IMAGE PROCESSING; INTERVENTIONAL RADIOLOGY; MALE; MEDICAL RESEARCH; METHODOLOGY; PROSTATE TUMOR; RADIOTHERAPY;

BIOMEDICAL RESEARCH; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; PROSTATIC NEOPLASMS; RADIOLOGY, INTERVENTIONAL; RADIOTHERAPY; SOFTWARE;

EID: 77951540327     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-25     Document Type: Review

References (41)

1. International Commission on Radiation Units Prescribing, recording and reporting photon beam therapy. ICRU Report 50. 1993, Bethesda International Commission on Radiation Units and Measurement MD:ICRU, International Commission on Radiation Units.
2. International Commission on Radiation Units Prescribing, recording and reporting photon beam therapy. Supplement to ICRU Report 50. 1999, Bethseda: International Commission on Radiation Units and Measurement. MD: ICRU, International Commission on Radiation Units.
3. Bhide S, Guerrero Urbano MT, Clark C, Hansen V, adams E, Miles E, McNair H, Warrington A, Harrington K, Nutting C. Results of intensity modulated radiotherapy (IMRT) in laryngeal and hypopharyngeal cancer: a dose escalation study. Radiother Oncol 2007, 82:S74-S75.
4. Peeters ST, Heemsbergen WD, Koper PC, van Putten WL, Slot A, Dielwart MF, Bonfrer JM, Incrocci L, Lebesque JV. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006, 24(13):1990-1996. 10.1200/JCO.2005.05.2530, 16648499.
5. Urbano TG, Clark CH, Hansen VN, Adams EJ, Miles EA, Mc Nair H, Bidmead AM, Warrington J, Dearnaley DP, Harmer C, Harrington KJ, Nutting CM. Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. Radiother Oncol 2007, 85(1):58-63. 10.1016/j.radonc.2007.07.020, 17904235.
6. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001, 166(3):876-881. 10.1016/S0022-5347(05)65855-7, 11490237.
7. Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, Low DA. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001, 49(4):07-916.
8. Eisbruch A, Marsh LH, Martel MK, Ship JA, Ten Haken R, Pu AT, Fraass BA, Lichter AS. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys 1998, 41(3):559-568. 10.1016/S0360-3016(98)00082-0, 9635702.
9. Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, Chepeha DB, Eisbruch A. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007, 68(5):1289-1298.
10. Nutting C, A'Hern R, Rogers MS, Sydenham MA, Adab F, Harrington K, Jefferies S, Scrase C, Yap BK, Hall E. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J Clin Oncol 2009, 27. 18S (abstr LBA6006).
11. Bhide SA, Harrington KJ, Nutting CM. Otological toxicity after postoperative radiotherapy for parotid tumours. Clin Oncol (R Coll Radiol) 2007, 19(1):77-82.
12. Zietman AL, DeSilvio ML, Slater JD, Rossi CJ, Miller DW, Adams JA, Shipley WU. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005, 294(10):1233-1239. 10.1001/jama.294.10.1233, 16160131.
13. Kupelian PA, Thakkar VV, Khuntia D, Reddy CA, Klein EA, Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 2005, 63(5):1463-1468. 10.1016/j.ijrobp.2005.05.054, 16169683.
14. Kupelian PA, Reddy CA, Carlson TP, Altsman KA, Willoughby TR. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. Int J Radiat Oncol Biol Phys 2002, 53(4):904-912.
15. Roach M, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, Rotman M, Jones C, Asbell SO, Valicenti RK, , et al. Radiation Therapy Oncology Group 9413 Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003, 21(10):1904-1911. 10.1200/JCO.2003.05.004, 12743142, Radiation Therapy Oncology Group 9413.
16. Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach M. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2006, 66(3):654-662.
17. Muren LP, Wasbo E, Helle SI, Hysing LB, Karlsdottir A, Odland OH, Valen H, Ekerold R, Johannessen DC. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences. Int J Radiat Oncol Biol Phys 2008, 71(4):1034-1041.
18. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, Roeske JC. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 52(5):1330-1337. 10.1016/S0360-3016(01)02785-7, 11955746.
19. Salama JK, Mundt AJ, Roeske J, Mehta N. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006, 65(4):1170-1176.
20. Lujan AE, Mundt AJ, Yamada SD, Rotmensch J, Roeske JC. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57(2):516-521. 10.1016/S0360-3016(03)00521-2, 12957265.
21. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56(5):1354-1360. 10.1016/S0360-3016(03)00325-0, 12873680.
22. Bockbrader M, Kim E. Role of intensity-modulated radiation therapy in gastrointestinal cancer. Expert Rev Anticancer Ther 2009, 9(5):637-647. 10.1586/era.09.16, 19445580.
23. Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, Vu TT, Truong P, Ackerman I, Paszat L. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008, 26(13):2085-2092. 10.1200/JCO.2007.15.2488, 18285602.
24. Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, Peckitt C, Reise S, Ross G, Sharp G, , et al. Breast Technology Group Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007, 82:254-264. 10.1016/j.radonc.2006.12.008, 17224195, Breast Technology Group.
25. Barnett GC, Wilkinson J, Moody AM, Wilson CB, Sharma R, Klager S, Hoole AC, Twyman N, Burnet NG, Coles CE. A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Radiother Oncol 2009, 92(1):34-41. 10.1016/j.radonc.2009.03.003, 19375808.
26. Madani I, Duthoy W, Derie C, De Gersem W, Boterberg T, Saerens M, Jacobs F, Gregoire V, Lonneux M, Vakaet L, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2007, 68(1):126-135.
27. Bentzen SM. Radiation therapy: intensity modulated, image guided, biologically optimized and evidence based. Radiother Oncol 2005, 77(3):227-230. 10.1016/j.radonc.2005.11.001, 16300846.
28. Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, Bridji B, Digue L, Toubeau M, Gregoire V. Positron emission tomography with [18f]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol 2010, 28:1190-1195. 10.1200/JCO.2009.24.6298, 20124179.
29. Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Gres B, El Balaa H, Keraudy K, Kerrou K, et al. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2005, 63(5):1432-1441. 10.1016/j.ijrobp.2005.05.016, 16125870.
30. Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, Lutolf UM, Steinert HC, Von Schulthess GK. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003, 57(3):853-863.
31. Bassi MC, Turri L, Sacchetti G, Loi G, Cannillo B, La Mattina P, Brambilla M, Inglese E, Krengli M. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 2008, 70(5):1423-1426.
32. Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005, 181(8):483-499. 10.1007/s00066-005-1422-7, 16044216.
33. Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001, 49(4):1171-1182. 10.1016/S0360-3016(00)01433-4, 11240261.
34. Lee NY, Mechalakos JG, Nehmeh S, Lin Z, Squire OD, Cai S, Chan K, Zanzonico PB, Greco C, Ling CC, Humm JL, Schöder H. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 2008, 70(1):2-13.
35. Verellen D, Ridder MD, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007, 7(12):949-960. 10.1038/nrc2288, 18034185.
36. Dawson LA, Jaffray DA. Advances in image-guided radiation therapy. J Clin Oncol 2007, 25(8):938-946. 10.1200/JCO.2006.09.9515, 17350942.
37. Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, Liao Z, Cox JD, Komaki R. Image-guided radiation therapy for non-small cell lung cancer. J Thorac Oncol 2008, 3(2):177-186. 10.1097/JTO.0b013e3181622bdd, 18303441.
38. Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 2010, 7(1):44-54. 10.1038/nrclinonc.2009.188, 19997074.
39. Suh JH. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010, 362(12):1119-1127. 10.1056/NEJMct0806951, 20335588.
40. Ma CM, Maughan RL. Within the next decade conventional cyclotrons for proton radiotherapy will become obsolete and replaced by far less expensive machines using compact laser systems for the acceleration of the protons. Med Phys 2006, 33(3):571-573. 10.1118/1.2150220, 16878559.
41. Laramore GE. Role of particle radiotherapy in the management of head and neck cancer. Curr Opin Oncol 2009, 21(3):224-231. 10.1097/CCO.0b013e328329b716, 19370806.